Trimedyne Gets OK for Laser Test: The...
- Share via
From Times Staff and Wire Reports
Trimedyne Gets OK for Laser Test: The Tustin biotech firm said the Food and Drug Administration cleared it to conduct human tests of its Holmium cold laser system to clear clogged heart arteries as an alternative to bypass surgery. Its stock rose 37.5 cents a share to $2.25 in over-the-counter trading on the news.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
